The filing signals CEO intent to sell a modest stake. Monitor for actual sale execution on Form 4 and any subsequent insider activity ahead of the next quarterly report.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 15 $95.45entry
- T+1 · 5w ago −0.73%α +0.37% · $94.75
- T+5 · 26d ago +1.19%α +2.21% · $96.59
- T+20 · 5d ago +5.80%α +7.70% · $100.99
- T+22 · todayOpen
- T+60 · in 8w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Medtronic CEO Geoffrey Martha filed a Form 144 notice of intent to sell 50,000 shares of common stock, with an estimated aggregate market value of approximately $4.75 million based on a filing price of $95.00 per share. The shares were acquired through restricted stock vesting and a stock option exercise dating back to 2018–2025, and the sale is planned through Fidelity Brokerage Services. While the dollar amount is modest relative to Martha's total holdings and Medtronic's market cap, a CEO sale ahead of the next earnings cycle warrants monitoring.
Key Facts
- Reporting owner: Geoffrey Martha (CEO, Director)
- Security type: Common stock
- Shares to be sold: 50,000
- Estimated aggregate market value: $4,750,000.00
- Price per share used for estimate: $95.00
- Broker: Fidelity Brokerage Services LLC
- Shares acquired from restricted stock vesting (2018, 2019, 2020, 2021, 2023) and a stock option exercise (January 2025)
- Filing date: October 15, 2026
- Date of determination to sell: July 16, 2026
- Shares outstanding (approximate): 1,279,137,890
Financial Impact
CEO intends to sell $4.75M worth of shares, representing ~0.004% of Medtronic's market cap based on the filing's share count.
Risk Factors
- Insider selling ahead of earnings could signal management's view on near-term performance
- Sale may not be completed; Form 144 is only an intent to sell
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007377 |
| Document: 0001959173-26-007377-index.html | 0001959173-26-007377 |
| Document: 0001959173-26-007377.txt | 0001959173-26-007377 |
Track record
53 reports on MDT
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +15.30% at T+60 after the Jun 3, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 16, 2026today Press Release Neutral 4/10 Entry price pending
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $101.59 Now $102.88 +1.27% settles Feb 8
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $98.88 Now $102.88 +4.05% settles Feb 1
- Oct 19, 202628d ago 8-K Neutral 4/10 Entry $94.63 Now $102.88 +8.72% settles Jan 15
- Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
- Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
- Oct 15, 20264w ago 144 Neutral 3/10 Viewing Entry $95.45 Now $102.88 +7.78% settles Jan 12
- Oct 14, 20264w ago SC TO-I/A Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
- Oct 14, 20264w ago 425 Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
- Oct 13, 20264w ago SC TO-I/A Neutral 5/10 Entry $93.01 Now $102.88 +10.61% settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers